ARTICLE | Company News
Cephalon, ImmuPharma deal
February 9, 2009 8:00 AM UTC
Cephalon exercised its option to license exclusive, worldwide rights to ImmuPharma's Lupuzor (formerly IPP-201101) to treat systemic lupus erythematosus (SLE). ImmuPharma will receive a $30 million ...